Category: Pharmacology

  • Week 1 Advanced Pharmacology

    There will be 2 different discussions in this post!!! Each discussion 250 words. This assignment will automatically submitted to turn it in so please DO NOT COPY FROM ANY ONLINE SOURCE!!! After you done please submit a plagiarism check and AI check to show that your work is authentic. My professor will read line by line so make sure to follow my instructions. PLEASE USE THE LEGIT SOURCE WITHIN 5 YEARS!! Please ensure to include one scholarly source for each post. Please use the textbook for this discussion. Textbook is uploaded in the file.

    Topic 1: High-Risk Medications in Older Adults

    Older adults are at increased risk for adverse drug events due to age-related changes in renal function, metabolism, and polypharmacy. The Beers Criteria, published by the American Geriatrics Society, outlines medications that may pose more risks than benefits in this population.

    Choose one medication listed in the Beers Criteria that youve seen used in clinical practice.

    1. Briefly explain why this drug is considered high-risk for older adults.
    2. Describe one or two key nursing implications (e.g., monitoring needs, side effects to watch for, patient teaching).
    3. If you feel this drug is still useful in some cases, explain why and include cautionary notes.

    Be sure to cite at least one scholarly or regulatory source in APA format (e.g., AGS, FDA, peer-reviewed journal).

    Topic 2: Pharmacology in the Era of Rapid Drug Development

    In recent years, we have seen a rapid pace in drug developmentfrom emergency authorizations during pandemics to fast-tracked approvals of breakthrough therapies.

    Select one recently approved drug (within the last 5 years) or one newly issued FDA/EMA/WHO drug safety warning. Briefly describe:

    1. What the drug is used for or what the warning was about
    2. How this reflects the evolving role of pharmacology in clinical practice
    3. Explain how one implication for advanced nursing practice is affected (e.g., prescribing, teaching, monitoring)

    Be sure to cite at least one current scholarly or regulatory source (e.g., FDA, WHO, peer-reviewed article) in APA format.

    Make sure to hit all the below highlights (use rubric for further guidance):

    • Clearly explain drug’s purpose or safety concern in an accurate and concise manner.
    • Thoughtfully connect the topic to current trends in pharmacology or drug regulation.
    • Provide one clear, relevant implication for the advanced practice nurse role (eg;, prescribing, education, monitoring).
    • Use at least one scholarly or regulatory source cited and referenced correctly in APA format.
    • Use clear, organized, professional tone.

    Attached Files (PDF/DOCX): Virginia Poole Arcangelo Andrew M Peterson Veronica Wilbur J – Pharmacotherapeutics for Advanced Practice_ A Practical Approach (2021 Wolters Kluwer Health) – libgenli.pdf

    Note: Content extraction from these files is restricted, please review them manually.

  • Infographic

    Many drugs have names that might sound like other drugs. This could cause confusion for the patient or provider and could lead to serious medical errors. Review the resources on this topic. Find a commonly known medication that has a look-alike, sound-alike name with another different medication. Create an infographic with the following information: Names of both drugs (generic and trade names) What is the primary indication (use) for each of the drugs? What are the typical dosage range, dosing schedule, and route for each drug? What are the most common side effects of each drug? What are the most serious (dangerous) side effects? How could you use the tall man lettering to help patients/staff who administer the medication distinguish between the 2 drugs? What other ideas might you use to prevent errors from receiving the wrong drug (for patients and/or providers)? Upload your infographic to this assignment link. Resources for the assignment: The problem of look-alike, sound-alike name errors: Drivers and solutions (Bryan et al., 2021) Includes “tall man” lettering. List of Confused Drug Names from the Institute for Safe Medicine Practices How look-alike, sound-alike drugs are commonly confused FDA List of Established Drug Names Recommended to Use Tall Man Lettering (TML) – a strategy to prevent look-alike, sound-alike drug errors. Infographic resources: What is an infographic? Piktochart – Register via the “Start for Free” tab for access to their free templates & design tools. HubSpot – 15 free templates when you register. Canva – Register as a “Student” for access to free templates & design tools. Creating Infographics in PowerPoint Creating Infographics in Google Slides Creating Infographics in Word or PowerPoint
  • mechanism of action of Aspirin.

    Aspirin is a commonly used drug that belongs to the class of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

    Mechanism of Action

    1. Aspirin inhibits the cyclooxygenase (COX) enzyme.
    2. This enzyme is responsible for the production of prostaglandins.
    3. Prostaglandins cause pain, inflammation, and fever in the body.
    4. By blocking COX enzymes, aspirin reduces prostaglandin synthesis.

    Effects

    • Reduces pain (analgesic effect)
    • Reduces fever (antipyretic effect)
    • Reduces inflammation (anti-inflammatory effect)
    • Prevents platelet aggregation, helping to reduce the risk of blood clots.
  • Experiential Activity

    TASK: Attend at least one recovery related event in your community. You can choose a number of events including but not limited to 12 step meetings, drug court hearings, or speakers talking about drug policy, addiction, prevention, or other related topic. Other events or activities may be permissible as well but you must attend them this semester and if you are at all unsure if an event qualifies contact your instructor. It is your responsibility to locate and select the activity you wish to attend.

    15 points:

    Detailed description of the event you attended including date, time, and location. Include

    why you selected the event, what happened, and who the participants were (i.e. number,

    gender, and estimate of age ranges names are not necessary). Describe how you were

    able to find the event including how easy the event was to find.

    15 points:

    Analysis of strengths and weaknesses of the event: Drawing on things you learned in

    class, do you think the event / activity would promote recovery? Are there certain types

    of people you think would benefit more from the event than others? Considering lessons

    learned in class, describe aspects that you believe tie into good practice / policy as well

    as aspects that were of concern.

    It is very important you explicitly connect some aspect of lessons from class to what

    you experience during this activity. This component is worth 5 points of this section

    alone; failure to do this will cost you 10% of your total grade on this paper!

    10 points:

    Describe your reaction to the event on an emotional level what was your gut

    reaction? How do you think an addict trying to get clean would respond to the event?

    Was the experience what you expected or something entirely different?

    10 points:

    Use proper grammar, punctuation, spelling, and organization. It is advisable to use

    headers to help organize main components of the paper.

    Attached Files (PDF/DOCX): Experiential Activity Paper.docx, Member Sharing.docx

    Note: Content extraction from these files is restricted, please review them manually.

  • Respiratory Drugs Presentation Project

    Respiratory Drugs Presentation Project

    You have been assigned to a topic related to a respiratory group of medications. Refer to Chapter 11 in your D2L content or respiratory drugs therapeutic class of drug cards (red and rust-colored). I also encourage you to do outside research for your presentations, including consultation of a pharmacist at a local community pharmacy for their recommendations on specific respiratory drug categories as listed below. You may submit a video, power-point slide with voiceovers, or another presentation-style project to the dropbox. Each participant must record their voice overs for their portion of the project.

    You must complete your project (worth 95 points), a partner evaluation (worth 2.5 points), and evaluate one other students project (worth 2.5 pts) for full credit. The project you evaluate must be a different topic from your project. This evaluation adds a learner-benefited exposure to additional areas of content for your respiratory drugs.

    You must present the following information for your respiratory project (worth 95 pts):

    • Background on the disease and/or symptoms assigned.
    • The various types of dosage forms available for your respiratory group of medications.
    • The advantages and disadvantages of the various dosage forms.
    • If a drug is controlled, indicate to which scheduled control group the medication(s) belongs.
    • Special precautions of which the patient should be aware, such as possible contraindications, allergy alerts, and or food interactions.
    • If medications within your group are also available OTC you must include pictures and prices contrasting options available for patients and the various price points of options (example, brand name Robitussin DM and its price vs. store brand/generic equivalent OTC to Robitussin DM).
    • Be sure to include the medications from your Siglers Drug Cards relevant to each respiratory group!
    • You may choose the type of presentation for your information (YouTube, Prezi, Canva, WebEx, etc.), but your project MUST include your voice in the presentation for full credit. Ten points are automatically deducted if there is no audio voice recording of presented information.
    • You must include documentation for all your information. Be sure to include your sources.

    Respiratory Topics

    (You may use multiple sources, D2L PowerPoints, and your Sigler’s Drug Cards to gather your research and information.)

    My topic is Bronchitis

    Below is a project from former students to use as an example. This is for reference only.

    Expand All Collapse All

    57.14 %4 of 7 topics complete

    List of Topics and Sub-Modules for Respiratory Drugs Presentation Project

  • reflection paper

    Attached Files (PDF/DOCX): NUR2474_Mod10_Grading Rubric_Written Reflection 14 pts.docx

    Note: Content extraction from these files is restricted, please review them manually.

  • Writer can create their own title

    The class is pharmacology, within a nursing program. The case study requires 2 sources for each question. Overall 4 total references. APA 7th edition formatting. The prompts for the case study are located in the doc below.

    Attached Files (PDF/DOCX): Final.docx

    Note: Content extraction from these files is restricted, please review them manually.

  • Mechanism of calcium channel blockers

    Calcium channel blockers (CCBs) inhibit the influx of calcium ions into heart muscle cells and smooth muscle cells of blood vessels.This prevents calcium-dependent contraction and conduction, causing vascular relaxation (vasodilation), reduced heart rate (negative chronotropy), and decreased cardiac contractility (negative inotropy)

    Requirements:

  • Senyawa dalam nigella sativa L yang paling berpotensi sebaga…

    Senyawa apa yang terkandung didalam tanaman nigella sativa L. Dengan potensi lebih tinggi dibandingkan dengan senyawa lainnya yang berpotensi sebagai newmedicine atau alternative medicine anticancer thyroid melalui pengaktivasian reseptor PPAR gamma

    Requirements:

  • Sleep disorders pharmacology

    Unit 11 Drug Reference Guide: Sleep Introduction Sleep disorders are common across clinical practice, and understanding the medications used to treat them is essential for safe and effective patient care. This assignment will guide you in exploring the primary drug classes prescribed for insomnia and other sleep-related conditions. Instructions Follow the instructions below to complete this assignment: Download the Template: Drug Reference Chart Template Download Drug Reference Chart Template[Word] Complete all required information listed in the chart for the medications provided below: Non-benzodiazepines: Suvorexant (Belsomra), Doxepin (Silenor), Zolpidem (Ambien), Zaleplon (Sonata), Eszopiclone (Lunesta). Melantonergic agents: Ramelteon Wake-promoting agents: Modafinil and Solriamfetol Off label Antidepressants used for insomnia: trazodone, mirtazapine Ensure you reference Stahls Essential Psychopharmacology Prescribers Guide for accuracy and completeness. Please review the provided rubric prior to submission to confirm that all criteria are met. Assignment Resources Use the following resource to help with this assignment (optional): Drug Reference Chart Template Download Drug Reference Chart Template[Word] Submit Submission Format Use the Drug Reference Chart Template and keep the assignment in a Word format Please review the provided rubric prior to submission to confirm that all criteria are met Due Sunday by 11:59 p.m. CT Estimated time to complete: 3 hours Rubric NU670: Unit 11 Assignment – Drug Reference Guide NU670: Unit 11 Assignment – Drug Reference Guide Criteria Ratings Pts This criterion is linked to a Learning OutcomeMedication Selection 2 pts Exemplary Accurately completes medications assigned by faculty; demonstrates clear understanding of each medications purpose and relevance to PMHNP practice. 1 pts Proficient Completes most assigned medications with generally accurate information; minor omissions noted. 0.5 pts Needs Improvement Missing several assigned medications or lacks clarity and completeness. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeFDA Indications 2 pts Exemplary Clearly and accurately lists FDA-approved indications using proper terminology; includes age/population specifics when applicable. 1 pts Proficient Includes most FDA indications but lacks specificity or omits minor details. 0.5 pts Needs Improvement Indications incomplete, unclear, or inaccurate. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeMechanism of Action 2 pts Exemplary Provides clear, concise, and accurate explanation demonstrating advanced understanding of pharmacodynamics and neurotransmitter activity. 1 pts Proficient Adequate explanation with minor gaps in accuracy or clarity. 0.5 pts Needs Improvement Limited or incorrect explanation of mechanism. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeSide & Adverse Effects 2 pts Exemplary Comprehensive and clinically prioritized list; identifies major risks and black box warnings where relevant. 1 pts Proficient Includes most effects with reasonable accuracy. 0.5 pts Needs Improvement Incomplete or inaccurate listing of effects. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeRequired Tests / Labs 2 pts Exemplary Accurately identifies baseline and ongoing lab requirements with rationale for monitoring. 1 pts Proficient Includes key labs but lacks rationale or detail. 0.5 pts Needs Improvement Missing or incorrect lab information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomePrecautions & Contraindications 2 pts Exemplary Accurately lists major contraindications, precautions, and drug interactions; includes relevant population considerations. 1 pts Proficient Addresses most precautions and contraindications with minor omissions. 0.5 pts Needs Improvement Incomplete or inaccurate information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeDosage Range / Dosage 2 pts Exemplary Provides accurate dosage ranges, available dosage forms (tablet, capsule, liquid, IM, etc.), and routes of administration; includes titration or adjustment parameters where applicable. 1 pts Proficient Includes general dosing information or partial list of dosage forms with minor gaps. 0.5 pts Needs Improvement Incomplete, inaccurate, or missing dosage details. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeAccuracy & Use of Evidence 2 pts Exemplary All information is accurate, current, and evidence-based using Stahls Essential Psychopharmacology/Prescribers Guide or other scholarly psychopharmacology sources. 1 pts Proficient Mostly accurate with minor unsupported details. 0.5 pts Needs Improvement Contains multiple inaccuracies or lacks credible evidence. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeOrganization & Professionalism 2 pts Exemplary Clear, well-organized, grammatically correct, and professionally formatted; easy to follow and visually clean. 1 pts Proficient Mostly organized and clear with few grammar or formatting errors. 0.5 pts Needs Improvement Disorganized, unclear, or unprofessional in presentation. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeCompleteness & Submission Quality 2 pts Exemplary All sections of the template are completed thoroughly and thoughtfully; demonstrates attention to detail. 1 pts Proficient Most sections complete but lacking in depth or thoroughness. 0.5 pts Needs Improvement Several sections incomplete or missing required information. 0 pts Absent No Submission 2 pts Total Points: 20